Showing results (531-540 of 6,022) with videos related to
Sort By:
Pageof 603
BMC Pregnancy and Childbirth|May 13, 2026
Robson ten-group classification-based analysis of caesarean sections in Türkiye: a large-scale cross-sectional studyCetin Samiloglu, Adil Barut, Gazi Guner, et al.International Journal of Rheumatic Diseases|October 27, 2022
The role of S100A12 and Toll-like receptor 4 in assessment of disease activity in familial Mediterranean fever and juvenile idiopathic arthritisSeyma Dumur, Amra Adrovic, Kenan Barut, et al.Cell Biochemistry and Biophysics|February 26, 2025
Modulation of the Oxidative Stress and ICAM-1/TLR4/NF-Κβ Levels by Metformin in Intestinal Ischemia/Reperfusion Injury in RatsInci Turan, Hale Sayan Ozacmak, Veysel Haktan Ozacmak, et al.Clinical & Experimental Optometry|November 25, 2024
Alterations in corneal sensitivity according to age and gender in healthy population in TurkeyNihat Furkan Eratilgan, Zeynep Akgun, Pelin Kiyat, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 28, 2003
Application of semi-industrial monolithic columns for downstream processing of clotting factor IXK Branović, A Buchacher, M Barut, et al.Analytical Chemistry|June 14, 2011
High-performance membrane chromatography of small moleculesA Podgornik, M Barut, J Jančar, et al.The Journal of Dermatology|March 1, 2011
Morbilliform drug eruption due to pegylated α-interferon can show complete regression after switching to non-pegylated interferonSener Barut, Jale Yuksek, Engin Sezer, et al.Pathology Oncology Research : POR|July 26, 2011
Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas?Nilufer Onak Kandemir, Figen Barut, Sibel Bektas, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|June 3, 2004
Is pipelle biopsy really adequate for diagnosing endometrial disease?H Alper Tanriverdi, Aykut Barut, Banu Dogan Gün, et al.Respiratory Medicine Case Reports|September 2, 2017
EML4-ALK-positive lung adenocarcinoma presenting an unusual metastatic pattern in a 29-year-old woman who is alive and well in her third year follow up:A case reportFatma Tokat, Handan Zeren, Pinar Barut, et al.Pageof 603